Roulex Laboratories Pvt. Ltd is an India’s emerging super specialty and innovation-led pharmaceutical organisation dedicated to reducing the cost of healthcare for chronic disorders such as chronic kidney disease, autoimmune, asthma, cardiovascular disease, to mention a few.
We are motivated by our desire to establish groundbreaking cutting-edge treatments in the world of super-specialty. We have obtained the trust of patients and doctors with our products that are secure, effective and affordable. We are continually committed to the pursuit of perfection in finding solutions that will absolutely cure our country and the world.
Our primary product line includes Alpha Keto Analogue, N Ascetylciectene & Taurine, Febuxostat and many more
EPA-DHA.
Antihypertensives ranges from , Clonidine Hcl, Benidipine Hcl , to ARBs and its combinations. Urology portfolio covers from Silodosin , Silodosin Dutasteride Dutastride, , Potassium Magnesium Citrate with Vitamin B6 to Febuxostat.
Scribnil-25 Cap is the brand in the country to its monopoly.
Our development relies on technological advancement, quality growth and transparency in all fields of our business.
We continue to apply the highest standards of ethics to our products, services and communications.
We are here to provide creative interventions that change the lives of patients and provide real benefits-from early warning and disease prevention, recovery and treatment tracking.
We build value by providing on the needs of patients. In Roulex Pharma, we aim to create a working atmosphere that encourages workers to achieve their full potential. We strive provide the investors with long-term returns while meeting patients' needs.
We are here to provide creative interventions that change the lives of patients and provide real benefits-from early warning and disease prevention, recovery and treatment tracking.